Atlas Trials

A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.

Clinical trial NCT05293522 · TERMINATED

Trial details

NCT number
NCT05293522
Sponsor
Neuraptive Therapeutics Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Facial Paralysis
Start date
2022-07-12
Primary completion
2023-08-22
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.